TNF and asthma: In obese mice, intraperitoneal administration of anti-TNF- monoclonal antibody significantly decreased lung matrix metallopeptidase 9 (MMP-9) activity, demonstrating a link between TNF- and increased asthma severity in obese subjects (Vieira et al., 2020).